Constitutive activation of NF-κB is a hallmark of several types of cancers, which not only promotes tumorigenesis and cancer development but also enhances drug resistance (Dolcet et al., 2005; Hanahan and Weinberg, 2000). Here, NFKB1 is linked to cancer.